
20 October 2025 - Public comment period now open until 17 November 2025; requests to make oral comment during public meeting also being accepted.
The ICER today released a draft evidence report assessing the comparative clinical effectiveness and value of cytisinicline (Achieve Life Sciences) for smoking cessation.